Edoxaban for the Treatment of Hypercoagulability and Cerebral Thromboembolism Associated with Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Edoxaban for the Treatment of Hypercoagulability and Cerebral Thromboembolism Associated with Cancer: A randomized clinical trial of biomarker targets
Int J Stroke 2024 Mar 01;[EPub Ahead of Print], JW Chung, J Hwang, HJ Kim, WK Seo, MJ Ahn, JL Saver, OY BangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.